191 related articles for article (PubMed ID: 32552343)
1. Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature.
Pérez CA; Patnaik A; Oommen S; Redko A; Mathis SB
J Child Neurol; 2020 Sep; 35(10):690-699. PubMed ID: 32552343
[TBL] [Abstract][Full Text] [Related]
2. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
3. Tumefactive demyelination: an approach to diagnosis and management.
Hardy TA; Chataway J
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1047-53. PubMed ID: 23334629
[TBL] [Abstract][Full Text] [Related]
4. Pediatric tumefactive demyelination: case series and review of the literature.
McAdam LC; Blaser SI; Banwell BL
Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
[TBL] [Abstract][Full Text] [Related]
5. [A case of pediatric multiple sclerosis presenting with a tumefactive demyelinating lesion].
Majima H; Ito T; Koyama N
Rinsho Shinkeigaku; 2017 Feb; 57(2):88-91. PubMed ID: 28132974
[TBL] [Abstract][Full Text] [Related]
6. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
7. Tumefactive Demyelination Appearing as Multiple Cystic Brain Lesions.
Wynne D; Hung Ho BK; Han TF
World Neurosurg; 2021 Sep; 153():6-8. PubMed ID: 34129977
[TBL] [Abstract][Full Text] [Related]
8. Tumefactive demyelinating lesions: a clinicopathological correlative study.
Neelima R; Krishnakumar K; Nair MD; Kesavadas C; Hingwala DR; Radhakrishnan VV; Nair SS
Indian J Pathol Microbiol; 2012; 55(4):496-500. PubMed ID: 23455787
[TBL] [Abstract][Full Text] [Related]
9. Relapsing Tumefactive Demyelination: A Case Report.
Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
[TBL] [Abstract][Full Text] [Related]
10. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
[TBL] [Abstract][Full Text] [Related]
11. Solitary tumefactive demyelinating lesions in children.
Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
[TBL] [Abstract][Full Text] [Related]
12. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
[TBL] [Abstract][Full Text] [Related]
13. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
14. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
Yiu EM; Laughlin S; Verhey LH; Banwell BL;
J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
[TBL] [Abstract][Full Text] [Related]
15. Tumour-like lesions in multiple sclerosis.
Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
[TBL] [Abstract][Full Text] [Related]
16. Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics.
Arenas Vargas LE; Bedoya Morales AM; Rincón Carreño C; Espitia Segura OM; Penagos N
Mult Scler Relat Disord; 2020 Sep; 44():102198. PubMed ID: 32531753
[TBL] [Abstract][Full Text] [Related]
17. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
[TBL] [Abstract][Full Text] [Related]
19. Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis.
Jackson-Tarlton CS; Keegan BM; Fereidan-Esfahani M; Barakat BO; Decker PA; Lucchinetti CF; Eckel-Passow J; Tobin WO
Mult Scler Relat Disord; 2023 May; 73():104614. PubMed ID: 36948092
[TBL] [Abstract][Full Text] [Related]
20. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]